Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Segment Information (Tables)

v3.10.0.1
Note 12 - Segment Information (Tables)
 3 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Quarter Ended
  
   
September 30,
  
   
2018
    
2017
  
Net sales:
                
Protein Sciences
   $
126,391
     $
108,113
  
Diagnostics and Genomics
    
36,747
      
36,589
  
Intersegment
    
(168
)
    
(89
)
Consolidated net sales
   $
162,970
     $
144,613
  
Operating income:
                
Protein Sciences
   $
54,614
     $
46,209
  
Diagnostics and Genomics
    
2,536
      
7,279
  
Segment operating income
    
57,150
      
53,488
  
Costs recognized on sale of acquired inventory
    
(935
)
    
(318
)
Amortization of acquisition related intangible assets
    
(14,276
)
    
(11,379
)
Acquisition related expenses
    
(2,631
)
    
(9,533
)
Stock-based compensation
    
(11,565
)
    
(3,795
)
Corporate general, selling, and administrative expenses
    
(1,980
)
    
(2,432
)
Consolidated operating income
   $
25,763
     $
26,031